Craig M. Lancaster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Craig M. Lancaster has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Scott Bradley Crowe
Royal Brisbane and Women’s Hospital
10 shared publications - Diana Binny
Radiation Oncology Centres, Redlands, Australia; Queensland University of Technology, Brisbane, Australia; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
8 shared publications - Jamie Vincent Trapp
School of Chemistry and Physics, Queensland University of Technology, Brisbane, Australia
7 shared publications - Tanya Kairn
Royal Brisbane and Women’s Hospital
6 shared publications Tanya Kairn
Queensland University of Technology, Brisbane, Australia; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
3 shared publications- Jeremy Ruben
Monash University, The Alfred Hospital, Melbourne, Victoria, Australia
2 shared publications
Latest Publications
- 2 August 2026
- Published by Springer Nature
- p. 503-514
Characteristics of a 9 MeV Electron Beam for Total Skin Electron Radiotherapy Evaluated in Comparison to a 6 MeV Electron Beam
- 2 August 2026
- Published by Springer Nature
- p. 503-514
Characteristics of a 9 MeV Electron Beam for Total Skin Electron Radiotherapy Evaluated in Comparison to a 6 MeV Electron Beam
- 14 February 2026
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 70 (3) , 322-330
Total Body Irradiation in Australia and New Zealand: A 2024 Practice Survey on Changing Patterns of Care
Introduction: Total body irradiation (TBI) practice varies globally. The optimal technique for TBI has not yet been determined, although guidelines and recommendations are available. Five years after the initial Australia and New Zealand (ANZ) practice survey in 2019, we report updated 2024 TBI practice patterns from 19 ANZ centres who are members of the ANZ Transplant and Cellular Therapies (ANZTCT) TBI Special Interest Group (TBISIG). Method: The 2024 survey was distributed in November 2024. Survey questions covered patient cohorts and caseloads, TBI regimens and dose‐fractionations, TBI techniques, planning considerations, quality assurance, and treatment delivery. For all centres, one staff member from each discipline (Radiation Oncology, Medical Physics, and Radiation Therapy) was invited to respond. Results: Responses were received from all 19 centres. Seven centres use modulated techniques in 2024, whereas only one centre delivered modulated TBI in 2019. Twelve centres use large open fields in 2024, six of which are considering changing to volumetric modulated arc therapy (VMAT) TBI. Compared to large open fields, modulated techniques (1) require dedicated patient immobilisation equipment and treatment planning software, (2) reduce dose to organs at risk (such as lungs and kidneys) below the prescription dose, (3) have higher dose rates, and (4) require more time for planning and treatment delivery. Conclusion: The 2024 survey showed diverse TBI practice patterns in ANZ. Compared to 2019, more centres are using or actively considering the implementation of modulated techniques, such as VMAT TBI, which adds to the complexity of treatment planning and delivery.
- 14 February 2026
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 70 (3) , 322-330
Total Body Irradiation in Australia and New Zealand: A 2024 Practice Survey on Changing Patterns of Care
Introduction: Total body irradiation (TBI) practice varies globally. The optimal technique for TBI has not yet been determined, although guidelines and recommendations are available. Five years after the initial Australia and New Zealand (ANZ) practice survey in 2019, we report updated 2024 TBI practice patterns from 19 ANZ centres who are members of the ANZ Transplant and Cellular Therapies (ANZTCT) TBI Special Interest Group (TBISIG). Method: The 2024 survey was distributed in November 2024. Survey questions covered patient cohorts and caseloads, TBI regimens and dose‐fractionations, TBI techniques, planning considerations, quality assurance, and treatment delivery. For all centres, one staff member from each discipline (Radiation Oncology, Medical Physics, and Radiation Therapy) was invited to respond. Results: Responses were received from all 19 centres. Seven centres use modulated techniques in 2024, whereas only one centre delivered modulated TBI in 2019. Twelve centres use large open fields in 2024, six of which are considering changing to volumetric modulated arc therapy (VMAT) TBI. Compared to large open fields, modulated techniques (1) require dedicated patient immobilisation equipment and treatment planning software, (2) reduce dose to organs at risk (such as lungs and kidneys) below the prescription dose, (3) have higher dose rates, and (4) require more time for planning and treatment delivery. Conclusion: The 2024 survey showed diverse TBI practice patterns in ANZ. Compared to 2019, more centres are using or actively considering the implementation of modulated techniques, such as VMAT TBI, which adds to the complexity of treatment planning and delivery.
- 1 January 2020
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 25 (1) , 35-40
In vivo monitoring of total skin electron dose using optically stimulated luminescence dosimeters
This study retrospectively analysed the results of using optically stimulated radiation dosimeters (OSLDs) for in vivo dose measurements during total skin electron therapy (TSET, also known as TSEI, TSEB, TSEBT, TSI or TBE) treatments of patients with mycosis fungoides. TSET treatments are generally delivered to standing patients, using treatment plans that are devised using manual dose calculations that require verification via in vivo dosimetry. Despite the increasing use of OSLDs for radiation dosimetry, there is minimal published guidance on the use of OSLDs for TSET verification. This study retrospectively reviewed in vivo dose measurements made during treatments of nine consecutive TSET patients, treated between 2013 and 2018. Landauer nanoDot OSLDs were used to measure the skin dose at reference locations on each patient, as well as at locations of clinical interest such as the head, hands, feet, axilla and groin. 1301 OSLD measurements were aggregated and analysed, producing results that were in broad agreement with previous TLD studies, while providing additional information about the variation of dose across concave surfaces and potentially guiding future refinement of treatment setup. In many cases these in vivo measurements were used to identify deviations from the planned dose in reference locations and to identify anatomical regions where additional shielding or boost treatments were required. OSLDs can be used to obtain measurements of TSET dose that can inform monitor unit adjustments and identify regions of under and over dosage, while potentially informing continuous quality improvement in TSET treatment delivery.
- 1 January 2020
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 25 (1) , 35-40
In vivo monitoring of total skin electron dose using optically stimulated luminescence dosimeters
This study retrospectively analysed the results of using optically stimulated radiation dosimeters (OSLDs) for in vivo dose measurements during total skin electron therapy (TSET, also known as TSEI, TSEB, TSEBT, TSI or TBE) treatments of patients with mycosis fungoides. TSET treatments are generally delivered to standing patients, using treatment plans that are devised using manual dose calculations that require verification via in vivo dosimetry. Despite the increasing use of OSLDs for radiation dosimetry, there is minimal published guidance on the use of OSLDs for TSET verification. This study retrospectively reviewed in vivo dose measurements made during treatments of nine consecutive TSET patients, treated between 2013 and 2018. Landauer nanoDot OSLDs were used to measure the skin dose at reference locations on each patient, as well as at locations of clinical interest such as the head, hands, feet, axilla and groin. 1301 OSLD measurements were aggregated and analysed, producing results that were in broad agreement with previous TLD studies, while providing additional information about the variation of dose across concave surfaces and potentially guiding future refinement of treatment setup. In many cases these in vivo measurements were used to identify deviations from the planned dose in reference locations and to identify anatomical regions where additional shielding or boost treatments were required. OSLDs can be used to obtain measurements of TSET dose that can inform monitor unit adjustments and identify regions of under and over dosage, while potentially informing continuous quality improvement in TSET treatment delivery.
- 1 September 2018
- Published by Elsevier in Physica Medica
- Vol. 53, 32-39
Tomotherapy treatment site specific planning using statistical process control
- 1 September 2018
- Published by Elsevier in Physica Medica
- Vol. 53, 32-39
Tomotherapy treatment site specific planning using statistical process control
- 20 August 2018
- Published by Springer Nature in Australasian Physics & Engineering Sciences in Medicine
- Vol. 41 (3) , 731-737
Characterisation of radiological properties of a brachytherapy moulding material
The use of a non-water-equivalent personalised mould for gynaecological brachytherapy treatments can result in a substantial dose reduction at the treatment site, compared to calculated dose, in lieu of a dose calculation algorithm capable of modelling non-water-equivalent materials. This study describes the characterisation of the radiological properties of a brachytherapy applicator moulding material. Simple line source correction factors for an 192Ir source are obtained through Monte Carlo simulations and verified by film measurements. The dwell position corrections are used to estimate aggregate correction factors for dose deliveries that involve multiple dwell positions, in terms of treatment length, applicator radii and depth of reference dose. For the Fricotan moulding material used locally, the dose reductions varied from 1% for an applicator radius of 0.5 cm to > 4% for radii exceeding 2 cm. The method described in this paper could be used to develop correction factors for other non-water-equivalent moulding materials, in a TG-43UI dose calculation environment.
- 20 August 2018
- Published by Springer Nature in Australasian Physics & Engineering Sciences in Medicine
- Vol. 41 (3) , 731-737
Characterisation of radiological properties of a brachytherapy moulding material
The use of a non-water-equivalent personalised mould for gynaecological brachytherapy treatments can result in a substantial dose reduction at the treatment site, compared to calculated dose, in lieu of a dose calculation algorithm capable of modelling non-water-equivalent materials. This study describes the characterisation of the radiological properties of a brachytherapy applicator moulding material. Simple line source correction factors for an 192Ir source are obtained through Monte Carlo simulations and verified by film measurements. The dwell position corrections are used to estimate aggregate correction factors for dose deliveries that involve multiple dwell positions, in terms of treatment length, applicator radii and depth of reference dose. For the Fricotan moulding material used locally, the dose reductions varied from 1% for an applicator radius of 0.5 cm to > 4% for radii exceeding 2 cm. The method described in this paper could be used to develop correction factors for other non-water-equivalent moulding materials, in a TG-43UI dose calculation environment.
- Open Access
- 30 May 2018
- Published by Springer Nature
- p. 437-442
Radiotherapy Quality Assurance Using Statistical Process Control
- 30 May 2018
- Published by Springer Nature
- p. 437-442
Open AccessRadiotherapy Quality Assurance Using Statistical Process Control
- 1 January 2018
- Published by Elsevier in Medical Dosimetry
- Vol. 43 (3) , 267-275
Photon optimizer (PO) vs progressive resolution optimizer (PRO): a conformality- and complexity-based comparison for intensity-modulated arc therapy plans
- 1 January 2018
- Published by Elsevier in Medical Dosimetry
- Vol. 43 (3) , 267-275
Photon optimizer (PO) vs progressive resolution optimizer (PRO): a conformality- and complexity-based comparison for intensity-modulated arc therapy plans
- Open Access
- 21 July 2017
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 18 (5) , 70-79
Statistical process control and verifying positional accuracy of a cobra motion couch using step‐wedge quality assurance tool
This study utilizes process control techniques to identify action limits for TomoTherapy couch positioning quality assurance tests. A test was introduced to monitor accuracy of the applied couch offset detection in the TomoTherapy Hi‐Art treatment system using the TQA “Step‐Wedge Helical” module and MVCT detector. Individual X‐charts, process capability (cp), probability (P), and acceptability (cpk) indices were used to monitor a 4‐year couch IEC offset data to detect systematic and random errors in the couch positional accuracy for different action levels. Process capability tests were also performed on the retrospective data to define tolerances based on user‐specified levels. A second study was carried out whereby physical couch offsets were applied using the TQA module and the MVCT detector was used to detect the observed variations.Random and systematic variations were observed for the SPC‐based upper and lower control limits, and investigations were carried out to maintain the ongoing stability of the process for a 4‐year and a three‐monthly period. Local trend analysis showed mean variations up to ±0.5 mm in the three‐monthly analysis period for all IEC offset measurements. Variations were also observed in the detected versus applied offsets using the MVCT detector in the second study largely in the vertical direction, and actions were taken to remediate this error. Based on the results, it was recommended that imaging shifts in each coordinate direction be only applied after assessing the machine for applied versus detected test results using the step helical module. User‐specified tolerance levels of at least ±2 mm were recommended for a test frequency of once every 3 months to improve couch positional accuracy. SPC enables detection of systematic variations prior to reaching machine tolerance levels. Couch encoding system recalibrations reduced variations to user‐specified levels and a monitoring period of 3 months using SPC facilitated in detecting systematic and random variations. SPC analysis for couch positional accuracy enabled greater control in the identification of errors, thereby increasing confidence levels in daily treatment setups.
- 21 July 2017
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 18 (5) , 70-79
Open AccessStatistical process control and verifying positional accuracy of a cobra motion couch using step‐wedge quality assurance tool
This study utilizes process control techniques to identify action limits for TomoTherapy couch positioning quality assurance tests. A test was introduced to monitor accuracy of the applied couch offset detection in the TomoTherapy Hi‐Art treatment system using the TQA “Step‐Wedge Helical” module and MVCT detector. Individual X‐charts, process capability (cp), probability (P), and acceptability (cpk) indices were used to monitor a 4‐year couch IEC offset data to detect systematic and random errors in the couch positional accuracy for different action levels. Process capability tests were also performed on the retrospective data to define tolerances based on user‐specified levels. A second study was carried out whereby physical couch offsets were applied using the TQA module and the MVCT detector was used to detect the observed variations.Random and systematic variations were observed for the SPC‐based upper and lower control limits, and investigations were carried out to maintain the ongoing stability of the process for a 4‐year and a three‐monthly period. Local trend analysis showed mean variations up to ±0.5 mm in the three‐monthly analysis period for all IEC offset measurements. Variations were also observed in the detected versus applied offsets using the MVCT detector in the second study largely in the vertical direction, and actions were taken to remediate this error. Based on the results, it was recommended that imaging shifts in each coordinate direction be only applied after assessing the machine for applied versus detected test results using the step helical module. User‐specified tolerance levels of at least ±2 mm were recommended for a test frequency of once every 3 months to improve couch positional accuracy. SPC enables detection of systematic variations prior to reaching machine tolerance levels. Couch encoding system recalibrations reduced variations to user‐specified levels and a monitoring period of 3 months using SPC facilitated in detecting systematic and random variations. SPC analysis for couch positional accuracy enabled greater control in the identification of errors, thereby increasing confidence levels in daily treatment setups.
- 1 June 2017
- Published by Elsevier in Physica Medica
- Vol. 38, 105-110
Investigating output and energy variations and their relationship to delivery QA results using Statistical Process Control for helical tomotherapy
- 1 June 2017
- Published by Elsevier in Physica Medica
- Vol. 38, 105-110
Investigating output and energy variations and their relationship to delivery QA results using Statistical Process Control for helical tomotherapy
- 1 November 2016
- Published by Elsevier in Physica Medica
- Vol. 32 (11) , 1479-1487
Monitoring Daily QA 3 constancy for routine quality assurance on linear accelerators
- 1 November 2016
- Published by Elsevier in Physica Medica
- Vol. 32 (11) , 1479-1487
Monitoring Daily QA 3 constancy for routine quality assurance on linear accelerators